{"SLR NAME":"The possibility and cause of relapse after previously recovered from COVID-19: a systematic review","References":[{"title1":"Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus avian infectious bronchitis virus"},{"title3":"Pathogenicity of turkey coronavirus in turkeys and chickens"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Severe acute respiratory syndrome"},{"title3":"SARS: epidemiology"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: a retrospective analysis on control interventions and superspreading events"},{"title3":"The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019-2020"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data"},{"title3":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings"},{"title3":"CDD/SPARCLE: functional classification of proteins via subfamily domain architectures"},{"title3":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination"},{"title3":"Parallelization of MAFFT for large-scale multiple sequence alignments"},{"title3":"RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"SWISS-MODEL: homology modelling of protein structures and complexes"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"}]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","References":[{"title3":"World Health Organization (WHO). Coronavirus. Geneva: WHO; 2020 [Accessed 21 Jan 2020]. Available from: https://www.who.int/health-topics/coronavirus "},{"title3":"Zhang Y-Z. Novel 2019 coronavirus genome. Virological. [Accessed 21 Jan 2020]. Available from: http://virological.org/t/novel-2019-coronavirus-genome/319 "},{"title3":"de Groot RJ, Baker SC, Baric R, Enjuanes L, Gorbalenya AE, Holmes KV, et al. Family Coronaviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ. Virus taxonomy: classification and nomenclature of viruses: ninth report of the International Committee on Taxonomy of Viruses. London; Waltham: Academic Press; 2012. p. 806-20."},{"title3":"The severe acute respiratory syndrome."},{"title3":"World Health Organization. (WHO. Novel Coronavirus (2019-nCoV). Situation report - 1. Geneva: WHO; 21 Jan 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf "},{"title3":"SARS testing: First past the post."},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Specific detection by real-time reverse-transcription PCR assays of a novel avian influenza A(H7N9) strain associated with human spillover infections in China."},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction."},{"title3":"Coordinated implementation of chikungunya virus reverse transcription-PCR."},{"title3":"Assay optimization for molecular detection of Zika virus."},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences."},{"title3":"Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission."},{"title3":"Hosts and sources of endemic human coronaviruses."},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS."},{"title3":"Origin and evolution of pathogenic coronaviruses."},{"title3":"The European Virus Archive goes global: A growing resource for research."},{"title3":"Developing a framework to assess the costeffectiveness of COMPARE - a global platform for the exchange of sequence-based pathogen data."},{"title3":"Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018."},{"title3":"First international external quality assessment of molecular diagnostics for Mers-CoV."},{"title3":"Advancing preparedness for clinical research during infectious disease epidemics."}]},{"title2":"WHO. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance. https://wwwwhoint/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117 (Accessed 4 February 2020). 2020.","References":[]},{"title2":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","References":[{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Geneva: World Health Organization, 2004 ()."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Influenza A virus shedding and infectivity in households."},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany."}]},{"title2":"Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression","References":[]}]},{"title1":"Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020","References":[{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia.","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.","References":[{"title3":"The Middle East Respiratory Syndrome (MERS)"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"Pneumonia in China: lack of information raises concerns among Hong Kong health workers"},{"title3":"Taking forward a' One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential"},{"title3":"ProMED &quot;Novel coronavirus - China (01): (HU) WHO, phylogenetic tree&quot;. Archive Number: 20200112.6885385. Accessed 13 Jan 2020. https://www.ecohealthalliance.org/2020/01/phylogenetic-analysis-shows-novel-wuhan-coronavirus-clusters-with-sars."}]},{"title2":"World Health Organization (WHO). World experts and funders set priorities for COVID-19 research. Geneva: WHO; 12 Feb 2020. Available from: https://www.who.int/news-room/detail/12-02-2020-world-experts-and-funders-set-priorities-for-covid-19-research ","References":[]},{"title2":"National Health Commission of the People's Republic of China. Update on the epidemic situation of the novel coronavirus pneumonia as at 24:00 on 4 Mar 2020. Beijing: National Health Commission of the People's Republic of China; 4 Mar 2020. Chinese. Available from: http://www.nhc.gov.cn/xcs/yqfkdt/202003/6e02433f7786402d8ea162fb5b80b5a0.shtml ","References":[]},{"title2":"National Institute for Viral Disease Control and Prevention (China). Specific primers and probes for detection 2019 novel coronavirus. Beijing: National Institute for Viral Disease Control and Prevention (China); 21 Jan 2020.Chinese. Available from: http://ivdc.chinacdc.cn/kyjz/202001/t20200121_211337.html ","References":[]},{"title2":"National Health Commission of the People's Republic of China. Diagnosis and treatment protocols of the novel coronavirus pneumonia (trial version 6). Beijing: National Health Commission of the People's Republic of China; 19 Feb 2020.Chinese. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf ","References":[]},{"title2":"China Daily Website. Recovered patient re-hospitalized after positive test. Beijing: China Daily Website; 21 Feb 2020. Chinese. Available from: http://ex.chinadaily.com.cn/exchange/partners/45/rss/channel/www/columns/2n8e04/stories/WS5e4fc442a31012821727963c.html ","References":[]},{"title2":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"},{"title3":"Serological evidence of bat SARS-related coronavirus infection in humans, China"},{"title3":"Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"}]},{"title2":"Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR.","References":[{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing"},{"title3":"Emerging Coronavirus 2019-nCoV Pneumonia"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia"}]},{"title2":"Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing.","References":[]},{"title2":"National Health Commission of Changde (China). Update on the epidemic situation of the novel coronavirus pneumonia in Changde on 10 Feb 2020. Changde: National Health Commission of Changde (China); 10 Feb 2020. Chinese. Available from: http://wjw.changde.gov.cn/zhdt/wjdt/content_718989 ","References":[]}]},{"title1":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study","References":[{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease","References":[]},{"title2":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection","References":[]},{"title2":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","References":[{"title3":"multi-country outbreak:update 34"},{"title3":"SARS coronavirus sequencing"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Atypical pneumonia"},{"title3":"Guideline on management of severe acute respiratory syndrome (SARS)"},{"title3":"HA guidelines on severe acute respiratory syndrome"},{"title3":"The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus acute respiratory distress syndrome"},{"title3":"Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response"},{"title3":"Prevention of experimental coronavirus colds with intranasal alpha-2b interferon"},{"title3":"Radiological appearances of cytomegalovirus infections"},{"title3":"A case of influenza bronchiolitis complicated by pneumomediastinum and subcutaneous emphysema"}]},{"title2":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings","References":[]},{"title2":"Consistent detection of 2019 novel coronavirus in saliva","References":[]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","References":[{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Geneva: World Health Organization, 2004 ()."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Influenza A virus shedding and infectivity in households."},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany."}]},{"title2":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study","References":[]},{"title2":"Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: a prospective cohort study","References":[]},{"title2":"Additional molecular testing of saliva specimens improves the detection of respiratory viruses","References":[{"title3":"Community-acquired pneumonia requiring hospitalization among US adults"},{"title3":"Community-acquired pneumonia requiring hospitalization among US children"},{"title3":"Community-acquired pneumonia"},{"title3":"What role do viruses play in nosocomial pneumonia"},{"title3":"Two years after pandemic influenza A/2009/H1N1: what have we learned"},{"title3":"The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities"},{"title3":"Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome"},{"title3":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Respiratory viruses and their impact in healthcare"},{"title3":"Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials"},{"title3":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data"},{"title3":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection"},{"title3":"The clinical impact of the detection of potential etiologic pathogens of community-acquired pneumonia"},{"title3":"A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a)"},{"title3":"Clinical management of human infection with pandemic (H1N1) 2009: revised guidance"},{"title3":"Viral pneumonia"},{"title3":"Comparison between saliva and nasopharyngeal swab specimens for detection of respiratory viruses by multiplex reverse transcription-PCR"},{"title3":"Comparison of sputum and nasopharyngeal swabs for detection of respiratory viruses"},{"title3":"FilmArray respiratory panel assay: comparison of nasopharyngeal swabs and bronchoalveolar lavage samples"},{"title3":"Unique reassortant of influenza A(H7N9) virus associated with severe disease emerging in Hong Kong"},{"title3":"Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus"},{"title3":"Bronchoalveolar lavage to diagnose respiratory infections"},{"title3":"Use of nasopharyngeal aspirate for diagnosis of pneumocystis pneumonia"},{"title3":"Multiple components contribute to ability of saliva to inhibit influenza viruses"},{"title3":"Salivary detection of H1N1 virus: a clinical feasibility investigation"},{"title3":"Surveillance of acute respiratory infections using community-submitted symptoms and specimens for molecular diagnostic testing"},{"title3":"Use of throat swab or saliva specimens for detection of respiratory viruses in children"},{"title3":"Evaluation of saliva as diagnostic materials for influenza virus infection by PCR-based assays"},{"title3":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation"},{"title3":"Lipid metabolites as potential diagnostic and prognostic biomarkers for acute community acquired pneumonia"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Comparison of the NucliSens easyMAG and Qiagen BioRobot 9604 nucleic acid extraction systems for detection of RNA and DNA respiratory viruses in nasopharyngeal aspirate samples"},{"title3":"2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings"},{"title3":"Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic"},{"title3":"Molecular diagnosis of respiratory viruses"},{"title3":"Clinical evaluation of the new high-throughput Luminex NxTAG respiratory pathogen panel assay for multiplex respiratory pathogen detection"},{"title3":"Assessment of antigen and molecular tests with serial specimens from a patient with influenza A(H7N9) infection"},{"title3":"Development and evaluation of novel real-time reverse transcription-PCR assays with locked nucleic acid probes targeting leader sequences of human-pathogenic coronaviruses"},{"title3":"The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment"},{"title3":"Flocked nasal swab versus nasopharyngeal aspirate in adult emergency room patients: similar multiplex PCR respiratory pathogen results and patient discomfort"},{"title3":"Centre for Health Protection. Recommended Personal Protective Equipment (PPE) in hospitals/clinics for suspected or confirmed cases with Middle East Respiratory Syndrome (MERS) under different response levels. Available at http://www.chp.gov.hk/en/guideline/11/35.html (accessed on 17 November 2015)."},{"title3":"Partial comparison of the NxTAG respiratory pathogen panel assay with the Luminex xTAG respiratory panel fast assay V2 and singleplex real-time polymerase chain reaction for detection of respiratory pathogens"}]},{"title2":"Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens","References":[]},{"title2":"Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia","References":[{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"Prospective study of the clinical progression and viral load of SARS-associated coronavirus pneumonia in a community outbreak"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"MP1 encodes an abundant and highly antigenic cell wall mannoprotein in the pathogenic fungus Penicillium marneffei"},{"title3":"Detection of specific antibodies to an antigenic mannoprotein for diagnosis of Penicillium marneffei penicilliosis"},{"title3":"Characterization of AFMP1: anovel target for serodiagnosis of aspergillosis"},{"title3":"Detection of specific antibodies to an antigenic cell wall galactomannoprotein for serodiagnosis of Aspergillus fumigatus aspergillosis"},{"title3":"Enzyme-linked immunosorbent assay for detecting antibodies to Borne disease virus-specific proteins"},{"title3":"An indirect ELISA for the detection of antibodies against porcine reproductive and respiratory syndrome virus using recombinant nucleocapsid protein as antigen"},{"title3":"Cloning and characterization of MalE in Burkholderia pseudomallei"},{"title3":"GroEL encodes a highly antigenic protein in Burkholderia pseudomallei"},{"title3":"AFLMP1 encodes an antigenic cell wall protein inAspergillus flavus"},{"title3":"Localization of linear B-cell epitopes on infectious bronchitis virus nucleocapsid protein"},{"title3":"Recombinant nucleocapsid protein is potentially an inexpensive, effective serodiagnostic reagent for infectious bronchitis virus"},{"title3":"An ELISA for antibodies against infectious bronchitis virus using an S1 spike polypeptide"},{"title3":"Detection of human coronavirus 229E-specific antibodies using recombinant fusion proteins"},{"title3":"Cost-effectiveness of rapid diagnosis of viral respiratory tract infections in pediatric patients"}]},{"title2":"Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains","References":[{"title3":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study"},{"title3":"Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017"},{"title3":"Impact of the 2014-2015 influenza season on the activity of an academic emergency department"},{"title3":"Management decision of hospital surge: assessing seasonal upsurge in inpatient medical bed occupancy rate among public acute hospitals in Hong Kong"},{"title3":"Economic burden of seasonal influenza in the United States"},{"title3":"Clinical characteristics and severity of influenza infections by virus type, subtype, and lineage: a systematic literature review"},{"title3":"Global circulation patterns of seasonal influenza viruses vary with antigenic drift"},{"title3":"Age-related differences in influenza B infection by lineage in a community-based sentinel system, 2010-2011 to 2015-2016, Canada"},{"title3":"Birth cohort effects in influenza surveillance data: evidence that first influenza infection affects later influenza-associated illness"},{"title3":"Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies"},{"title3":"Antibody to influenza virus neuraminidase: an independent correlate of protection"},{"title3":"Low population serum microneutralization antibody titer against the predominating influenza A(H3N2) N121K virus during the severe influenza summer peak of Hong Kong in 2017"},{"title3":"Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection"},{"title3":"High incidence of severe influenza among individuals over 50 years of age"},{"title3":"Two years after pandemic influenza A/2009/H1N1: what have we learned?"},{"title3":"Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza"},{"title3":"GISAID: Global initiative on sharing all influenza data - from vision to reality"},{"title3":"FAMSA: Fast and accurate multiple sequence alignment of huge protein families"},{"title3":"International laboratory comparison of influenza microneutralization assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) influenza viruses by CONSISE"},{"title3":"Development and application of monoclonal antibodies-based antigen capture ELISA for detecting nucleocapsid protein of Influenza A virus"},{"title3":"Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial"},{"title3":"High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza"},{"title3":"Local situation of influenza activity (as of Jan 9, 2019)"},{"title3":"Differential effects of prior influenza exposures on H3N2 cross-reactivity of human postvaccination sera"},{"title3":"The evolution of seasonal influenza viruses"},{"title3":"A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014-2015 season"},{"title3":"Mapping the antigenic and genetic evolution of influenza virus"},{"title3":"Evolution-informed forecasting of seasonal influenza A (H3N2)"},{"title3":"Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses"},{"title3":"Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains"}]},{"title2":"Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63","References":[]},{"title2":"Viral load kinetics of MERS coronavirus infection","References":[]},{"title2":"Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A(H3N2) infection: an open-label randomized, controlled, phase IIb/III trial","References":[]},{"title2":"Treatment With lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset","References":[{"title3":"HIV-associated tuberculosis in children and adolescents: evolving epidemiology, screening, prevention and management strategies"},{"title3":"Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers"},{"title3":"Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review"},{"title3":"Lopinavir-ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir-ritonavir without rifampicin: a pharmacokinetic modelling and clinical study"},{"title3":"Lopinavir exposure is insufficient in children given double doses of lopinavir/ritonavir during rifampicin-based treatment for tuberculosis"},{"title3":"Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trial"},{"title3":"Blood sample volumes in child health research: review of safe limits"},{"title3":"Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography"},{"title3":"The international interlaboratory quality control program for measurement of antiretroviral drugs in plasma: a global proficiency testing program"},{"title3":"Plasma lopinavir concentrations predict virological failure in a cohort of South African children initiating a protease-inhibitor-based regimen"},{"title3":"Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children"},{"title3":"Establishing dosing recommendations for efavirenz in HIV/TB-Coinfected children younger than 3 years"},{"title3":"Pharmacokinetics and safety of a raltegravir-containing regimen in children aged 4 Weeks to 2 Years living with human immunodeficiency virus and receiving rifampin for tuberculosis"},{"title3":"Pharmacokinetic interaction between raltegravir and rifampicin in an infant with HIV exposed to active TB: a case report"},{"title3":"Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment"},{"title3":"Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial"},{"title3":"Dolutegravir as first- or second-line treatment for HIV-1 infection in children"},{"title3":"Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial"}]},{"title2":"Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors","References":[{"title3":"Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an a-extra helical domain"},{"title3":"Coronavirus main protease (3CLpro) structure: basis for design of anti-SARS drugs"},{"title3":"Protein flexibility and drug design: how to hit a moving target"},{"title3":"Accommodating protein flexibility in computational drug design"},{"title3":"A second generation force-field for the simulation of proteins, nucleic acids, and organic molecules"},{"title3":"Epidermiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"HIV-1 protease flaps spontaneously open and reclose in molecular dynamics simulations"},{"title3":"HIV-1 protease flaps spontaneously close to the correct structure in simulations following manual placement of an inhibitor into the open state"},{"title3":"Mechanism of the maturation process of SARS-CoV 3CL protease"},{"title3":"3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism"},{"title3":"Identifying inhibitors of the SARS coronavirus proteinase"},{"title3":"Comparison of simple potential functions for simulating liquid water"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide"},{"title3":"Computational drug design accommodating receptor flexibility: the relaxed complex scheme"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"A general and fast scoring function for protein-ligand interactions: a simplified potential approach"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Numerical integration of the Caresian equations of motion of a system with constraints: molecular dynamics of n-alkanes"},{"title3":"Implications of protein flexibility for drug discovery"},{"title3":"Old drugs for a new bug: influenza, HIV drugs enlisted to fight SARS"},{"title3":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus"},{"title3":"The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor"},{"title3":"Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main protease with HIV, psychotic and parasite drugs"}]},{"title2":"Initial viral load and the outcomes of SARS","References":[]},{"title2":"Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms","References":[]},{"title2":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"},{"title3":"Serological evidence of bat SARS-related coronavirus infection in humans, China"},{"title3":"Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"}]},{"title2":"Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals","References":[{"title3":"Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein"},{"title3":"Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein"},{"title3":"SARS coronavirus: A new challenge for prevention and therapy"},{"title3":"SARS-associated coronavirus"},{"title3":"Virology. The SARS coronavirus: A postgenomic era"},{"title3":"Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid"},{"title3":"Profile of specific antibodies to the SARS-associated coronavirus"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients"},{"title3":"The Genome sequence of the SARS-associated coronavirus"},{"title3":"Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Diagnosis of severe acute respiratory syndrome (SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay"},{"title3":"Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients"},{"title3":"Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Severe acute respiratory syndrome: Radiographic appearances and pattern of progression in 138 patients"},{"title3":"Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia"},{"title3":"Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus"},{"title3":"Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia"},{"title3":"The complete genome sequence of severe acute respiratory syndrome coronavirus strain HKU-39849 (HK-39)"}]},{"title2":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection","References":[]},{"title2":"Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus","References":[{"title3":"Middle East respiratory syndrome coronavirus intra-host populations are characterized by numerous high frequency variants"},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk"},{"title3":"Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia"},{"title3":"Massively parallel pyrosequencing in HIV research"},{"title3":"Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus"},{"title3":"Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study"},{"title3":"Viral population estimation using pyrosequencing"},{"title3":"Complete genome sequence of Middle East respiratory syndrome coronavirus KOR/KNIH/002_05_2015, Isolated in South Korea"},{"title3":"Variations in spike glycoprotein gene of MERS-CoV, South Korea, 2015"},{"title3":"The recent ancestry of Middle East respiratory syndrome coronavirus in Korea has been shaped by recombination"},{"title3":"Spread of mutant Middle East respiratory syndrome coronavirus with reduced affinity to human CD26 during the South Korean Outbreak"},{"title3":"Detection and quantification of rare mutations with massively parallel sequencing"},{"title3":"Quasispecies theory and the behavior of RNA viruses"},{"title3":"Unbiased estimation of the rates of synonymous and nonsynonymous substitution"},{"title3":"Fast and accurate long-read alignment with Burrows-Wheeler transform"},{"title3":"The sequence alignment/map format and SAMtools"},{"title3":"Complete genome sequence of Middle East respiratory syndrome coronavirus (MERS-CoV) from the first imported MERS-CoV case in China"},{"title3":"Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus"},{"title3":"Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients"},{"title3":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data"},{"title3":"Middle East respiratory syndrome coronavirus superspreading event involving 81 persons, Korea 2015"},{"title3":"Evolution of the Zfx and Zfy genes: rates and interdependence between the genes"},{"title3":"Isolation of Middle East respiratory syndrome coronavirus from a patient of the 2015 Korean Outbreak"},{"title3":"Microevolution of outbreak-associated Middle East respiratory syndrome coronavirus, South Korea, 2015"},{"title3":"MEGA6: molecular evolutionary genetics analysis version 6.0"},{"title3":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution"},{"title3":"Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population"},{"title3":"Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in China: phylogenetics and coalescence analysis"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"}]},{"title2":"Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis","References":[{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong."},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong."},{"title3":"Identification of severe acute respiratory syndrome in Canada."},{"title3":"Update: outbreak of severe acute respiratory syndrome:worldwide."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome."},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome."},{"title3":"Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions."},{"title3":"Transmission dynamics and control of the severe acute respiratory syndrome."},{"title3":". Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). [cited 2004 Feb 18]. Available from: http://www.who.int /csr/sars/en/index.html"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":". Case definitions for surveillance of SARS. [cited 2003 May 1]. Available from: http://www.who.int/csr/sars/casedefinition/en/"},{"title3":"Severe acute respiratory syndrome:Taiwan 2003."},{"title3":". Interim domestic infection control precautions for aerosol-generating procedures on patients with severe acute respiratory syndrome (SARS). [cited 2003 Oct 4]. Available from: http://www.cdc.gov/ncidod/sars/aerosolinfectioncontrol.htm"},{"title3":". Interim laboratory biosafety guidelines for handling and processing specimens associated with severe acute respiratory syndrome (SARS). [cited 2003 Oct 4]. Available from: http://www.cdc.gov/ncidod/sars/sarslabguide.htm"},{"title3":"Microbiologic characterization, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan."},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"The genome sequence of the SARS-associated coronavirus."},{"title3":"Detection of dengue virus replication in peripheral blood mononuclear cells from dengue virus type 2-infected patients by a reverse transcription-real-time PCR assay."},{"title3":"Avoiding false positive with PCR."},{"title3":"Lung pathology of fatal severe acute respiratory syndrome."},{"title3":"Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS)."},{"title3":"Cluster of severe acute respiratory syndrome cases among protected health-care workers:Toronto, Canada, April 2003."},{"title3":". Sampling for severe acute respiratory syndrome (SARS) diagnostic tests. [cited 2003 Oct 4]. Available from: http://www.who.int/csr/sars/sampling/en/"},{"title3":". Guidelines for collection of specimens from potential cases of SARS. [cited 2003 Dec 26]. Available from: http://www.cdc.gov/ncidod/sars/specimen_collection_sars2.htm"},{"title3":"Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality."}]},{"title2":"Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus avian infectious bronchitis virus"},{"title3":"Pathogenicity of turkey coronavirus in turkeys and chickens"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Severe acute respiratory syndrome"},{"title3":"SARS: epidemiology"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: a retrospective analysis on control interventions and superspreading events"},{"title3":"The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019-2020"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data"},{"title3":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings"},{"title3":"CDD/SPARCLE: functional classification of proteins via subfamily domain architectures"},{"title3":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination"},{"title3":"Parallelization of MAFFT for large-scale multiple sequence alignments"},{"title3":"RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"SWISS-MODEL: homology modelling of protein structures and complexes"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"}]},{"title2":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43","References":[]}]},{"title1":"Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients","References":[{"title2":"New SARS-like virus in China triggers alarm","References":[]},{"title2":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"Structure, Function, and Evolution of Coronavirus Spike Proteins"},{"title3":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex"},{"title3":"Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion"},{"title3":"Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding"},{"title3":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen"},{"title3":"Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion"},{"title3":"Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains"},{"title3":"Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis"},{"title3":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination"},{"title3":"The 3.1-Angstrom Cryo-electron Microscopy Structure of the Porcine Epidemic Diarrhea Virus Spike Protein in the Prefusion Conformation"},{"title3":"Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy"},{"title3":"Pre-fusion structure of a human coronavirus spike protein"},{"title3":"Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide"},{"title3":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites"},{"title3":"Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation"},{"title3":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2"},{"title3":"Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody"},{"title3":"Leginon: an automated system for acquisition of images from vitreous ice specimens"},{"title3":"Real-time cryo-electron microscopy data preprocessing with Warp"},{"title3":"Automatic local resolution-based sharpening of cryo-EM maps"},{"title3":"PHENIX: building new software for automated crystallographic structure determination"},{"title3":"ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps"},{"title3":"Coot: model-building tools for molecular graphics"},{"title3":"Collaboration gets the most out of software"},{"title3":"cisTEM, user-friendly software for single-particle image processing"}]},{"title2":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","References":[]},{"title2":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","References":[{"title3":"SARS-CoV infection in a restaurant from palm civet"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2"},{"title3":"Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease"},{"title3":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy"},{"title3":"Host cell proteases: critical determinants of coronavirus tropism and pathogenesis"},{"title3":"Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus"},{"title3":"Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection"},{"title3":"Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro"},{"title3":"Two mutations were critical for bat-to-human transmission of Middle East respiratory syndrome coronavirus"},{"title3":"Trypsin treatment unlocks barrier for zoonotic bat coronaviruses infection"},{"title3":"Conformational reorganization of the SARS coronavirus spike following receptor binding: implications for membrane fusion"},{"title3":"Molecular diversity of coronaviruses in bats"},{"title3":"Further evidence for bats as the evolutionary source of Middle East respiratory syndrome coronavirus"},{"title3":"A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry"},{"title3":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels"},{"title3":"Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission"},{"title3":"Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses"},{"title3":"Adaptive evolution of MERS-CoV to species variation in DPP4"},{"title3":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature10.1038/s41586-020-2012-7 (2020)."},{"title3":"Wan, Y., Shang, J., Graham, R., Baric, R. S. &amp; Li, F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J. Virol.10.1128/JVI.00127-20 (2020)."},{"title3":"RNA recombination in a coronavirus: recombination between viral genomic RNA and transfected RNA fragments"},{"title3":"Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission"},{"title3":"Seifert, S. N. et al. Rousettus aegyptiacus bats do not support productive Nipah virus replication. J. Infect. Dis.10.1093/infdis/jiz429 (2019)."},{"title3":"A system for functional analysis of Ebola virus glycoprotein"}]},{"title2":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","References":[{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19"},{"title3":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors"},{"title3":"Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and prostate cancer susceptibility"},{"title3":"Cell entry mechanisms of SARS-CoV-2"},{"title3":"Tissue ACE phenotyping in prostate cancer"},{"title3":"Effects of the angiotensin-I-converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells"},{"title3":"Clinical characteristics and results of semen tests among men with coronavirus disease 2019"},{"title3":"Role of proprotein convertases in prostate cancer progression"},{"title3":"Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells"},{"title3":"Inflammation-induced oxidative stress mediates gene fusion formation in prostate cancer"},{"title3":"Androgens and androgen receptor signaling in prostate tumorigenesis"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2"},{"title3":"The trinity of COVID-19: immunity, inflammation and intervention"},{"title3":"Epigenetic impact of infection on carcinogenesis: mechanisms and applications"},{"title3":"Prostate cancer and inflammation: the evidence"}]},{"title2":"Lv, H. et al. Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections. Cell Rep. In press. 10.1016/j.celrep.2020.107725 (2020).","References":[]},{"title2":"Wu, F. et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. Available at SSRN: 10.2139/ssrn.3566211 (2020).","References":[]},{"title2":"A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2","References":[{"title3":"Automatic Generation of Validated Specific Epitope Sets"},{"title3":"Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope"},{"title3":"Investigation of immunogenic T-cell epitopes in SARS virus nucleocapsid protein and their role in the prevention and treatment of SARS infection"},{"title3":"Specific epitopes of the structural and hypothetical proteins elicit variable humoral responses in SARS patients"},{"title3":"Correction: Definition of Human Epitopes Recognized in Tetanus Toxoid and Development of an Assay Strategy to Detect Ex Vivo Tetanus CD4+ T Cell Responses"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"IEDB-AR: immune epitope database-analysis resource in 2019"},{"title3":"ImmunomeBrowser: a tool to aggregate and visualize complex and heterogeneous epitopes in reference proteins"},{"title3":"Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas"},{"title3":"Cutting Edge: Transcriptional Profiling Reveals Multifunctional and Cytotoxic Antiviral Responses of Zika Virus-Specific CD8+ T Cells"},{"title3":"SARS corona virus peptides recognized by antibodies in the sera of convalescent cases"},{"title3":"Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library"},{"title3":"BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes"},{"title3":"NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data"},{"title3":"Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a"},{"title3":"YASARA View - molecular graphics for all devices - from smartphones to workstations"},{"title3":"Reliable B cell epitope predictions: impacts of method development and improved benchmarking"},{"title3":"Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates"},{"title3":"New allele frequency database: http://www.allelefrequencies.net"},{"title3":"HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity"},{"title3":"A population response analysis approach to assign class II HLA-epitope restrictions"},{"title3":"Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes"},{"title3":"TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates"},{"title3":"ViPR: an open bioinformatics database and analysis resource for virology research"},{"title3":"Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities"},{"title3":"Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long-lasting immunity"},{"title3":"HLA class I supertypes: a revised and updated classification"},{"title3":"From SARS to MERS, Thrusting Coronaviruses into the Spotlight"},{"title3":"Human T Cell Response to Dengue Virus Infection"},{"title3":"HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins"},{"title3":"The Immune Epitope Database (IEDB): 2018 update"},{"title3":"Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus"},{"title3":"Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates"},{"title3":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China"},{"title3":"Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals"},{"title3":"Immune epitope database analysis resource (IEDB-AR)"}]},{"title2":"Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV","References":[{"title3":"World Health Organization (WHO), Statement on the second meeting of the International Health Regulations (2005). Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)."},{"title3":"Severe acute respiratory syndrome-related coronavirus - The species and its viruses, a statement of the Coronavirus Study Group"},{"title3":"Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727-733 (2020)."},{"title3":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)"},{"title3":"Tian, X. et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg. Microbes Infect. 9, 382-385 (2020)."},{"title3":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature (2020)."},{"title3":"Qiu, T. et al. Identification of potential cross-protective epitope between 2019-nCoV and SARS virus. J. Genet. Genomics (2020)."},{"title3":"BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes"},{"title3":"Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2"},{"title3":"SWISS-MODEL: homology modelling of protein structures and complexes"}]},{"title2":"Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies","References":[{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"Centers-of-Disease-Control-and-Prevention Confirmed 2019-nCoV cases globally"},{"title3":"World-Health-Organization Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)"},{"title3":"World-Health-Organization Coronavirus disease (COVID-19) outbreak"},{"title3":"World-Health-Organization Statement on the meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Data sharing and outbreaks: Best practice exemplified"},{"title3":"Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"World-Health-Organization Update 49 - SARS case fatality ratio, incubation period"},{"title3":"World-Health-Organization Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding"},{"title3":"Functional assessment of cell entry and receptor usage for lineage B beta-coronaviruses, including 2019-nCoV"},{"title3":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells"},{"title3":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice"},{"title3":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants"},{"title3":"A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease"},{"title3":"Identification of an epitope of SARS-coronavirus nucleocapsid protein"},{"title3":"Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus"},{"title3":"Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients"},{"title3":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: A six-year follow-up study"},{"title3":"Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients"},{"title3":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection"},{"title3":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection"},{"title3":"T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection"},{"title3":"MAFFT multiple sequence alignment software version 7: Improvements in performance and usability"},{"title3":"ViPR: An open bioinformatics database and analysis resource for virology research"},{"title3":"The immune epitope database (IEDB): 2018 update"},{"title3":"PASTA: Ultra-large multiple sequence alignment for nucleotide and amino-acid sequences"},{"title3":"Dendroscope 3: An interactive tool for rooted phylogenetic trees and networks"},{"title3":"Data and software code for reproducing results of this paper"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Coordinate linkage of HIV evolution reveals regions of immunological vulnerability"},{"title3":"Statistical linkage analysis of substitutions in patient-derived sequences of genotype 1a hepatitis C virus nonstructural protein 3 exposes targets for immunogen design"},{"title3":"Sub-dominant principal components inform new vaccine targets for HIV Gag"},{"title3":"Co-evolution networks of HIV/HCV are modular with direct association to structure and function"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies"},{"title3":"Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R"},{"title3":"UniProt UniProtKB - P59594 (SPIKE_CVHSA)"},{"title3":"Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein"},{"title3":"Unexpected receptor functional mimicry elucidates activation of coronavirus fusion"},{"title3":"Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion"},{"title3":"Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody"},{"title3":"Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design"},{"title3":"Rational design of vaccine targets and strategies for HIV: A crossroad of statistical physics, biology, and medicine"},{"title3":"Identifying immunologically-vulnerable regions of the HCV E2 glycoprotein and broadly neutralizing antibodies that target them"},{"title3":"Fitness landscape of the human immunodeficiency virus envelope protein that is targeted by antibodies"},{"title3":"Deconvolving mutational patterns of poliovirus outbreaks reveals its intrinsic fitness landscape"},{"title3":"The fitness landscape of HIV-1 Gag: Advanced modeling approaches and validation of model predictions by in vitro testing"},{"title3":"Insights into cross-species evolution of novel human coronavirus 2019-nCoV and defining immune determinants for vaccine development"}]},{"title2":"Wang, H. et al. SARS-CoV-2 proteome microarray for mapping COVID-19 antibody interactions at amino acid resolution. Preprint at: https://doi.org/10.1101/2020.03.26.994756 (2020).","References":[]},{"title2":"Characterisation of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide","References":[]},{"title2":"Fusion peptide in the spike protein of MERS coronavirus","References":[{"title3":"Coronaviruses: Important Emerging Human Pathogens"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Osterhaus AD FR. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia"},{"title3":"Bat origin of human coronaviruses Coronaviruses: Emerging and re-emerging pathogens in humans and animals Susanna Lau Positive-strand RNA viruses"},{"title3":"SARS-CoV and emergent coronaviruses: Viral determinants of interspecies transmission"},{"title3":"Receptor Recognition Mechanisms of Coronaviruses: A Decade of Structural Studies"},{"title3":"Genomic Characterization of Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein"},{"title3":"Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains"},{"title3":"Structure, Function, and Evolution of Coronavirus Spike Proteins"},{"title3":"Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2"},{"title3":"MERS-CoV spike protein: A key target for antivirals"},{"title3":"The many mechanisms of viral membrane fusion proteins"},{"title3":"Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide"},{"title3":"Mechanisms of coronavirus cell entry mediated by the viral spike protein"},{"title3":"Characterization of a Highly Conserved Domain within the Severe Acute Respiratory Syndrome Coronavirus Spike Protein S2 Domain with Characteristics of a Viral Fusion Peptide"},{"title3":"The SARS-CoV Fusion Peptide Forms an Extended Bipartite Fusion Platform that Perturbs Membrane Order in a Calcium-Dependent Manner"},{"title3":"Phases and phase transitions of the phosphatidylcholines"},{"title3":"Influenza Virus M2 Protein Mediates ESCRT-Independent Membrane Scission"},{"title3":"Prediction of amphipathic in-plane membrane anchors in monotopic proteins using a SVM classifier"},{"title3":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites"},{"title3":"A camel-derived MERS-CoV with a variant spike protein cleavage site and distinct fusion activation properties"},{"title3":"Multiple membrane interactions and versatile vesicle deformations elicited by melittin"},{"title3":"Proteolytic Activation of the Spike Protein at a Novel RRRR/S Motif Is Implicated in Furin-Dependent Entry, Syncytium Formation, and Infectivity of Coronavirus Infectious Bronchitis Virus in Cultured Cells"},{"title3":"Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein"},{"title3":"The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection"},{"title3":"Protective effect of intranasal regimens containing peptidic middle east respiratory syndrome coronavirus fusion inhibitor against MERS-CoV infection"},{"title3":"Sar1p N-terminal helix initiates membrane curvature and completes the fission of a COPII vesicle"}]},{"title2":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody","References":[{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies"},{"title3":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets"},{"title3":"Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants"},{"title3":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association"},{"title3":"An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus"},{"title3":"Coronavirus spike proteins in viral entry and pathogenesis"},{"title3":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Structural insights into immune recognition of the severe acute respiratory syndrome coronavirus S protein receptor binding domain"},{"title3":"Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Unexpected receptor functional mimicry elucidates activation of coronavirus fusion"},{"title3":"Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody"}]},{"title2":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","References":[{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus Deltacoronavirus supports bat coronaviruses as the gene source of Alphacoronavirus and Betacoronavirus and avian coronaviruses as the gene source of Gammacoronavirus and Deltacoronavirus"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Acute life threatening event (ALTE) in an infant with human coronavirus HCoV-229E infection"},{"title3":"Human coronavirus OC43 associated with fatal encephalitis"},{"title3":"Fatal outcome of human coronavirus NL63 infection despite successful viral elimination by IFN-alpha in a patient with newly diagnosed ALL"},{"title3":"Molecular epidemiology and evolutionary histories of human coronavirus OC43 and HKU1 among patients with upper respiratory tract infections in Kuala Lumpur, Malaysia"},{"title3":"Identification and evolutionary dynamics of two novel human coronavirus OC43 genotypes associated with acute respiratory infections: Phylogenetic, spatiotemporal and transmission network analyses"},{"title3":"Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"SARS-like WIV1-CoV poised for human emergence"},{"title3":"Two mutations were critical for bat-to-human transmission of Middle East Respiratory Syndrome coronavirus"},{"title3":"Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5"},{"title3":"Bat-to-human: Spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein"},{"title3":"Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines"},{"title3":"Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness"},{"title3":"Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: Implications for virus fusogenic mechanism and identification of fusion inhibitors"},{"title3":"HIV-1 inhibition by a peptide"},{"title3":"Peptides corresponding to a predictive alpha-helical domain of human-immunodeficiency-virus type 1 gp41 are potent inhibitors of virus-infection"},{"title3":"A trimeric structural subdomain of the HIV-1 transmembrane glycoprotein"},{"title3":"Heptad-repeat regions of respiratory syncytial virus F1 protein form a six-membered coiled-coil complex"},{"title3":"Functional importance of the coiled-coil of the Ebola virus glycoprotein"},{"title3":"Membrane fusion machines of paramyxoviruses: Capture of intermediates of fusion"},{"title3":"Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein"},{"title3":"The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex"},{"title3":"Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor"},{"title3":"Influence of hydrophobic and electrostatic residues on SARS-coronavirus S2 protein stability: Insights into mechanisms of general viral fusion and inhibitor design"},{"title3":"Core structure of S2 from the human coronavirus NL63 spike glycoprotein"},{"title3":"Remodeling of gp41-C34 peptide leads to highly effective inhibitors of the fusion of HIV-1 with target cells"},{"title3":"Helix stabilization by Glu-...Lys+ salt bridges in short peptides of de novo design"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Protective effect of intranasal regimens containing peptidic Middle East respiratory syndrome coronavirus fusion inhibitor against MERS-CoV infection"},{"title3":"A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes"},{"title3":"HIV-1 virion fusion assay: Uncoating not required and no effect of Nef on fusion"},{"title3":"Studies of Ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: Involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha"},{"title3":"A catalytically and genetically optimized beta-lactamase-matrix based assay for sensitive, specific, and higher throughput analysis of native henipavirus entry characteristics"},{"title3":"Crystal structure of the post-fusion core of the human coronavirus 229E spike protein at 1.86 A resolution"},{"title3":"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies"},{"title3":"Recombinant receptor-binding domains of multiple Middle East respiratory syndrome coronaviruses (MERS-CoVs) induce cross-neutralizing antibodies against divergent human and camel MERS-CoVs and antibody escape mutants"},{"title3":"Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on MERS-CoV spike glycoprotein to avoid neutralization escape"},{"title3":"Receptor recognition mechanisms of coronaviruses: A decade of structural studies"},{"title3":"Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides"},{"title3":"HIV gp41 C-terminal heptad repeat contains multifunctional domains. Relation to mechanisms of action of anti-HIV peptides"},{"title3":"De novo design of alpha-helical lipopeptides targeting viral fusion proteins: A promising strategy for relatively broad-spectrum antiviral drug discovery"},{"title3":"Discovery of hydrocarbon-stapled short alpha-helical peptides as promising middle east respiratory syndrome coronavirus (MERS-CoV) fusion inhibitors"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2"},{"title3":"The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases"},{"title3":"Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease"},{"title3":"Type II transmembrane serine proteases in cancer and viral infections"},{"title3":"Clinical isolates of human coronavirus 229E bypass the endosome for cell entry"},{"title3":"Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry"},{"title3":"Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China"},{"title3":"Human coronavirus and acute respiratory illness in older adults with chronic obstructive pulmonary disease"},{"title3":"Severity and outcome associated with human coronavirus OC43 infections among children"},{"title3":"A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses"},{"title3":"Processing of X-ray diffraction data collected in oscillation mode"},{"title3":"PHENIX: A comprehensive Python-based system for macromolecular structure solution"},{"title3":"Coot: Model-building tools for molecular graphics"},{"title3":"MolProbity: All-atom structure validation for macromolecular crystallography"},{"title3":"PDB2PQR: An automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations"},{"title3":"SWISS-MODEL: Modelling protein tertiary and quaternary structure using evolutionary information"},{"title3":"Determination of the helix and beta form of proteins in aqueous solution by circular dichroism"},{"title3":"Determination of the HIV-1 gp41 fusogenic core conformation modeled by synthetic peptides: Applicable for identification of HIV-1 fusion inhibitors"},{"title3":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies"},{"title3":"Novel treatment with neuroprotective and antiviral properties against a neuroinvasive human respiratory virus"},{"title3":"Biopolymeric nano/microspheres for selective and reversible adsorption of coronaviruses"},{"title3":"Blocking of exchange proteins directly activated by cAMP leads to reduced replication of Middle East respiratory syndrome coronavirus"},{"title3":"Bilateral entry and release of Middle East respiratory syndrome coronavirus induces profound apoptosis of human bronchial epithelial cells"},{"title3":"Vacuolating encephalitis in mice infected by human coronavirus OC43"},{"title3":"Pharmacokinetics on a microscale: Visualizing Cy5-labeled oligonucleotide release from poly(n- butylcyanoacrylate) nanocapsules in cells"},{"title3":"MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model"}]},{"title2":"The 2019 novel coronavirus resource","References":[{"title3":"for the Intensive Care Chapter of Indian Academy of Pediatrics. Novel coronavirus 2019 (2019-nCoV) infection: Part I -Preparedness and management in the pediatric intensive care unit in resource-limited settings"},{"title3":"Coronavirus Disease-19 Among Children outside Wuhan, China (Internet"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Care for critically ill patients with COVID-19"},{"title3":"Consensus statement: Safe airway society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group"},{"title3":"Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: Implications for management of pandemic influenza and other airborne infections"},{"title3":"Transmission of influenza: Implications for control in health care settings"},{"title3":"The airborne transmission of infection in hospital buildings: Fact or fiction?"},{"title3":"Critical care crisis and some recommendations during the COVID-19 epidemic in China"},{"title3":"for the China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Surviving sepsis campaign: Guidelines on the management of critically Ill adults with coronavirus disease 2019 (COVID-19)"},{"title3":"Effectiveness of noninvasive positive pressure ventilation in the treatment of acute respiratory failure in severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation"},{"title3":"Infection and control of epidemic-and pandemic-prone acute respiratory diseases in health care"},{"title3":"Noninvasive ventilation for patients with acute lung injury or acute respiratory distress syndrome"},{"title3":"Clinical characteristics and outcomes of patients with 2009 influenza A (H1N1) virus infection with respiratory failure requiring mechanical ventilation"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Influenza virus in human exhaled breath: an observational study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"The Intensive Care Society recommended bundle of interventions for the prevention of ventilator-associated pneumonia"}]},{"title2":"Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products","References":[]},{"title2":"Novel differential linear B-cell epitopes to identify Zika and dengue virus infections in patients","References":[]},{"title2":"Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein","References":[{"title3":"A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection"},{"title3":"Chikungunya virus infection. A retrospective study of 107 cases"},{"title3":"Expression and evaluation of Chikungunya virus E1 and E2 envelope proteins for serodiagnosis of Chikungunya virus infection"},{"title3":"Expression of the capsid protein of Chikungunya virus in a baculovirus for serodiagnosis of Chikungunya disease"},{"title3":"High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis"},{"title3":"Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay"},{"title3":"Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218"},{"title3":"The influence of maternal immunization on infant immune responses"},{"title3":"Chikungunya virus arthritis in adult wild-type mice"},{"title3":"Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Reunion"},{"title3":"Roles and reactivities of antibodies to alphaviruses"},{"title3":"Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160"},{"title3":"Structural basis of influenza virus neutralization"},{"title3":"Comparative immunogenicities of chikungunya vaccines prepared in avian and mammalian tissues"},{"title3":"Production and evaluation of a formalin-killed Chikungunya vaccine"},{"title3":"Differential processing of sindbis virus glycoprotein PE2 in cultured vertebrate and arthropod cells"},{"title3":"Chikungunya: a bending reality"},{"title3":"Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response"},{"title3":"The 2005-2006 Chikungunya epidemic in the Indian Ocean"},{"title3":"A nonhuman primate model of chikungunya disease"},{"title3":"The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity"},{"title3":"Chikungunya: a review"},{"title3":"Chikungunya disease outbreak, Reunion Island"},{"title3":"Immuno-biology of Chikungunya and implications for disease intervention"},{"title3":"Early appearance of neutralizing IgG3-antibodies is associated with Chikungunya virus clearance and long-term clinical protection"},{"title3":"Characterization of a major neutralization domain of Ross river virus using anti-viral and anti-peptide antibodies"},{"title3":"Why Chikungunya is called Chikungunya"},{"title3":"Characterisation of a chikungunya virus from a German patient returning from Mauritius and development of a serological test"},{"title3":"Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages"},{"title3":"Chikungunya outbreak, Singapore, 2008"},{"title3":"Development of an attenuated strain of chikungunya virus for use in vaccine production"},{"title3":"Biological differences in rAAV transduction of airway epithelia in humans and in old world non-human primates"},{"title3":"An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-1953. II. General description and epidemiology"},{"title3":"Efficient diagnosis of vulvovaginal candidiasis by use of a new rapid immunochromatography test"},{"title3":"The use of nonhuman primate models in HIV vaccine development"},{"title3":"A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence"},{"title3":"Immune response to dengue virus and prospects for a vaccine"},{"title3":"Clinical features and epidemiology of chikungunya infection in Singapore"},{"title3":"Immune responses against multiple epitopes: a theory for immunodominance and antigenic variation"},{"title3":"Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein"},{"title3":"IgG placental transfer in healthy and pathological pregnancies"},{"title3":"Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006"},{"title3":"UCSF Chimera - a visualization system for exploratory research and analysis"},{"title3":"Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism"},{"title3":"Chikungunya"},{"title3":"Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus"},{"title3":"Clinical burden of chikungunya virus infection"},{"title3":"A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006"},{"title3":"An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features"},{"title3":"Chikungunya virus of Asian and Central/East African genotypes in Malaysia"},{"title3":"Reduced surface: an efficient way to compute molecular surfaces"},{"title3":"Structural proteins of Chikungunya virus"},{"title3":"Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses"},{"title3":"Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases"},{"title3":"Replication cycle of chikungunya: a re-emerging arbovirus"},{"title3":"Identification of antigenically important domains in the glycoproteins of Sindbis virus by analysis of antibody escape variants"},{"title3":"The alphaviruses: gene expression, replication, and evolution"},{"title3":"Entomological investigation and control of a chikungunya cluster in Singapore"},{"title3":"Host responses to Chikungunya virus and perspectives for immune-based therapies"},{"title3":"Chikungunya: a potentially emerging epidemic"},{"title3":"Furin at the cutting edge: from protein traffic to embryogenesis and disease"},{"title3":"Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus"},{"title3":"Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography"},{"title3":"A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis"},{"title3":"Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency"},{"title3":"Chikungunya fever in Singapore: acute clinical and laboratory features, and factors associated with persistent arthralgia"},{"title3":"Island biogeography reveals the deep history of SIV"},{"title3":"Evaluation of Chikungunya diagnostic assays: differences in sensitivity of serology assays in two independent outbreaks"},{"title3":"Furin processing and proteolytic activation of Semliki Forest virus"}]},{"title2":"Type I interferon shapes the quantity and quality of the anti-Zika virus antibody response","References":[{"title3":"One-step RT-PCR for detection of Zika virus"},{"title3":"Potential sexual transmission of Zika virus"},{"title3":"Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014"},{"title3":"Zika virus infection in mice causes panuveitis with shedding of virus in tears"},{"title3":"Zika virus associated with microcephaly"},{"title3":"Zika virus: from an obscurity to a priority"},{"title3":"A mouse model of Zika virus pathogenesis"},{"title3":"Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro "},{"title3":"Action and reaction: the arthropod-borne flaviviruses and host interferon responses"},{"title3":"Characterization of a novel murine model to study Zika virus"},{"title3":"Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection"},{"title3":"Zika virus targets human STAT2 to inhibit type I interferon signaling"},{"title3":"Zika virus inhibits type-I interferon production and downstream signaling"},{"title3":"Type I IFN signaling on both B and CD4 T cells is required for protective antibody response to adenovirus"},{"title3":"Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo "},{"title3":"Interferon-driven deletion of antiviral B cells at the onset of chronic infection"},{"title3":"Type I interferon suppresses virus-specific B cell responses by modulating CD8+ T cell differentiation"},{"title3":"Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections"},{"title3":"Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein"},{"title3":"A chimeric Zika virus between viral strains MR766 and BeH819015 highlights a role for E-glycan loop in antibody-mediated virus neutralization"},{"title3":"Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models"},{"title3":"Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system"},{"title3":"Persistence of Zika virus in body fluids - final report"},{"title3":"Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination"},{"title3":"Lymphoid hyperplasia resulting in immune dysregulation is caused by porcine reproductive and respiratory syndrome virus infection in neonatal pigs"},{"title3":"Quantifying specific antibody concentrations by enzyme-linked immunosorbent assay using slope correction"},{"title3":"Comparative genomics, infectivity and cytopathogenicity of American isolates of Zika virus that developed persistent infections in human embryonic kidney (HEK293) cells"},{"title3":"Efficiencies and kinetics of infection in different cell types/lines by African and Asian strains of Zika virus"},{"title3":"The human antibody response to dengue virus infection"},{"title3":"B-cell responses during primary and secondary dengue virus infections in humans"},{"title3":"Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology"},{"title3":"Type 1 interferons and the virus-host relationship: a lesson in detente"},{"title3":"Neuropathogenesis of Zika virus in a highly susceptible immunocompetent mouse model after antibody blockade of type I interferon"},{"title3":"Zika virus infection damages the testes in mice"},{"title3":"TAM receptors are not required for Zika virus infection in mice"},{"title3":"An immunocompetent mouse model of Zika virus infection"},{"title3":"Cellular and humoral immunity protect against vaginal Zika virus infection in mice"},{"title3":"Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope"},{"title3":"Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west Nile virus encephalitis cases"},{"title3":"Estimation of dengue virus IgM persistence using regression analysis"},{"title3":"Dendritic cells control B cell growth and differentiation"},{"title3":"Viral persistence induces antibody inflation without altering antibody avidity"},{"title3":"Host defense pathways: role of redundancy and compensation in infectious disease phenotypes"},{"title3":"IgG2a restriction of murine antibodies elicited by viral infections"},{"title3":"Activation of mouse complement by different classes of mouse antibody"},{"title3":"An essential role of antibodies in the control of Chikungunya virus infection"},{"title3":"A poorly neutralizing IgG2a/c response elicited by a DNA vaccine protects mice against Japanese encephalitis virus"},{"title3":"Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response"},{"title3":"Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein"},{"title3":"Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection"},{"title3":"Harmful and beneficial antibodies in immune thrombocytopenic purpura"},{"title3":"Immunoglobulin isotype influences affinity and specificity"},{"title3":"T-bet regulates IgG class switching and pathogenic autoantibody production"},{"title3":"The role of T cells in immunoglobulin class switching of specific antibody production system in vitro in humans"},{"title3":"Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice"},{"title3":"T lymphocyte dependence of the antibody response to 'T lymphocyte independent type 2' antigens"},{"title3":"Germinal center B cell dynamics"},{"title3":"CD4+ T cells promote humoral immunity and viral control during Zika virus infection"},{"title3":"Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cells"},{"title3":"Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex"},{"title3":"Dengue virus control of type I IFN responses: a history of manipulation and control"},{"title3":"In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection"},{"title3":"Guillain-Barre syndrome and anti-ganglioside antibodies: a clinician-scientist's journey"},{"title3":"Role of type I interferons in the activation of autoreactive B cells"},{"title3":"Persistence of Zika virus in conjunctival fluid of convalescence patients"},{"title3":"The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice"},{"title3":"A sensitive method for detecting Zika virus antigen in patients' whole-blood specimens as an alternative diagnostic approach"}]},{"title2":"Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus","References":[]},{"title2":"Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibody","References":[{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"SARS-beginning to understand a new virus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The Genome sequence of the SARS-associated coronavirus"},{"title3":"Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions"},{"title3":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"The SARS-CoV S glycoprotein: expression and functional characterization"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Structural characterization of the SARS-coronavirus spike S fusion protein core"},{"title3":"Characterization of the heptad repeat regions, HR1 and HR2, and design of a fusion core structure model of the spike protein from severe acute respiratory syndrome (SARS) coronavirus"},{"title3":"Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein"},{"title3":"Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core"},{"title3":"Cellular entry of the SARS coronavirus"},{"title3":"Characterization of the prefusion and transition states of severe acute respiratory syndrome coronavirus S2-HR2"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"The spike protein of SARS-CoV-a target for vaccine and therapeutic development"},{"title3":"Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention"},{"title3":"An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus"},{"title3":"Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine"},{"title3":"Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential"},{"title3":"Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein"},{"title3":"Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing"},{"title3":"Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus"},{"title3":"Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents"},{"title3":"Production of influenza pseudotyped lentiviral particles and their use in influenza research and diagnosis: an update"},{"title3":"Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein"},{"title3":"Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2"},{"title3":"S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients"},{"title3":"Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes"},{"title3":"Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants"},{"title3":"Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein"},{"title3":"A human SARS-CoV neutralizing antibody against epitope on S2 protein"},{"title3":"A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial"},{"title3":"Evolutionary insights into the ecology of coronaviruses"},{"title3":"Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission"},{"title3":"A review of studies on animal reservoirs of the SARS coronavirus"},{"title3":"Virus entry: molecular mechanisms and biomedical applications"},{"title3":"Human monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanisms"},{"title3":"Fully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a rhesus macaque SARS model"},{"title3":"B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein"},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences"},{"title3":"Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge"},{"title3":"Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies"},{"title3":"A single amino acid substitution in the S1 and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV"},{"title3":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex"},{"title3":"The SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterization"},{"title3":"Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein"}]},{"title2":"Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore","References":[]}]},{"title1":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin","References":[]},{"title2":"Serological evidence of bat SARS-related coronavirus infection in humans, China","References":[{"title3":"Understanding human coronavirus HCoV-NL63"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China"},{"title3":"Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein"},{"title3":"Bat origin of human coronaviruses"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A line immunoassay utilizing recombinant nucleocapsid proteins for detection of antibodies to human coronaviruses"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"SARS-like WIV1-CoV poised for human emergence"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Duration of antibody responses after severe acute respiratory syndrome"},{"title3":"Epidemiologic clues to SARS origin in China"},{"title3":"Isolation and characterization of a novel bat coronavirus closely related to the direct progenitor of severe acute respiratory syndrome coronavirus"}]},{"title2":"Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases","References":[]},{"title2":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways","References":[{"title3":"  . Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. http://www.who.int [2003]."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"A 193-amino-acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"The SARS-CoV S glycoprotein: expression and functional characterization"},{"title3":"The secret life of ACE2 as a receptor for the SARS virus"},{"title3":"Interaction between the heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implication for virus fusogenic mechanism and identification of fusion inhibitors"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Identification of an epitope of SARS-coronavirus nucleocapsid protein"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Fatal aspergillosis in a patient with SARS who was treated with corticosteroids"},{"title3":"Rapid and efficient preparation of monoclonal antibodies against SARS-associated coronavirus nucleocapsid protein by immunizing mice"},{"title3":"Increased localization and substrate activation of protein kinase C delta in lung epithelial cells following exposure to asbestos"},{"title3":"Clinical detection of polymerase gene of SARS-associated coronavirus"},{"title3":"Antibody response of patients with severe acute respiratory syndrome (SARS) to nucleocapsid antigen of SARS-associated coronavirus"},{"title3":"SARS in China. The big question now: will it be back?"},{"title3":"Infectious diseases: Singapore lab faulted in SARS case"},{"title3":"Study on etiology and pathology of severe acute respiratory syndrome"},{"title3":"Human aminopeptidase N is a receptor for human coronavirus 229E"},{"title3":"Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV"},{"title3":"Aminopeptidase N inhibitors and SARS"},{"title3":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"SARS: protecting against a deadly disease"}]},{"title2":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus","References":[{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"World Health Organization, MERS-CoV Outbreak Update (World Health Organization, 2017); www.who.int/emergencies/mers-cov/en/."},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study"},{"title3":"Middle East respiratory syndrome coronavirus: Another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Unraveling the drivers of MERS-CoV transmission"},{"title3":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014"},{"title3":"Stability of Middle East respiratory syndrome coronavirus in milk"},{"title3":"Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013"},{"title3":"Middle East respiratory syndrome coronavirus: Transmission, virology and therapeutic targeting to aid in outbreak control"},{"title3":"Middle East respiratory syndrome coronavirus: Epidemiology and disease control measures"},{"title3":"Probable transmission chains of Middle East respiratory syndrome coronavirus and the multiple generations of secondary infection in South Korea"},{"title3":"Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions"},{"title3":"Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea"},{"title3":"Understanding viral transmission behavior via protein intrinsic disorder prediction: Coronaviruses"},{"title3":"Prediction of intrinsic disorder in MERS-CoV/HCoV-EMC supports a high oral-fecal transmission"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium"},{"title3":"Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer"},{"title3":"Modeling rotavirus infection and antiviral therapy using primary intestinal organoids"},{"title3":"Stem cell-derived human intestinal organoids as an infection model for rotaviruses"},{"title3":"Alternative functional in vitro models of human intestinal epithelia"},{"title3":"Multi-organ damage in human dipeptidyl peptidase 4 transgenic mice infected with Middle East respiratory syndrome-coronavirus"},{"title3":"Characterization and demonstration of the value of a lethal mouse model of Middle East respiratory syndrome coronavirus infection and disease"},{"title3":"Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4"},{"title3":"Emerging viral respiratory tract infections:Environmental risk factors and transmission"},{"title3":"Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus"},{"title3":"Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures"},{"title3":"Middle East respiratory syndrome coronavirus infection: Virus-host cell interactions and implications on pathogenesis"},{"title3":"P. J. Quin, B. K. Markey, F. C. Leonard, E. S. Fitzpatrick, S. Fanning, P. Hartigan, Veterinary Microbiology and Microbial Disease (Wiley-Blackwell, ed. 2, 2011)."},{"title3":"Rapid inactivation of rotaviruses by exposure to acid buffer or acidic gastric juice"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013"},{"title3":"Systemic dissemination of H5N1 influenza A viruses in ferrets and hamsters after direct intragastric inoculation"},{"title3":"Hepatitis A virus: From discovery to vaccines"},{"title3":"An outbreak of coronavirus OC43 respiratory infection in Normandy, France"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways"},{"title3":"Crossing barriers: Infections of the lung and the gut"},{"title3":"Bovine respiratory coronavirus"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: Implications for pathogenesis"},{"title3":"Kruppel-like factor 15 activates hepatitis B virus gene expression and replication"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"}]}]}]}